Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MCK Mckesson Corp
- Stocks
- Healthcare
- NYSE: MCK
Price (delayed)
$709.41
Market cap
$88.76B
P/E Ratio
27.43
Dividend/share
$2.84
EPS
$25.86
Enterprise value
$90.45B
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company had revenues of $231.1 billion in 2020. McKesson is
Highlights
The debt has declined by 24% since the previous quarter
The company's EPS rose by 18% QoQ and by 15% YoY
MCK's equity is up by 33% since the previous quarter but it is down by 5% year-on-year
The price to earnings (P/E) is 16% more than the 5-year quarterly average of 23.8 and 6% more than the last 4 quarters average of 25.9
Mckesson's gross margin has decreased by 12% YoY and by 5% from the previous quarter
Key stats
What are the main financial stats of MCK
Market
Valuations
Earnings
Shares outstanding
125.11M
Market cap
$88.76B
Enterprise value
$90.45B
Price to earnings (P/E)
27.43
Price to book (P/B)
N/A
Price to sales (P/S)
0.25
EV/EBIT
20.38
EV/EBITDA
17.01
EV/Sales
0.25
Revenue
$359.05B
Gross profit
$13.32B
Operating income
$4.42B
Net income
$3.3B
EBIT
$4.44B
EBITDA
$5.32B
Free cash flow
$5.23B
Per share
Balance sheet
Liquidity
EPS
$25.86
EPS diluted
$25.72
Free cash flow per share
$41.02
Book value per share
-$16.55
Revenue per share
$2,818.3
TBVPS
$499.64
Total assets
$75.14B
Total liabilities
$76.83B
Debt
$7.39B
Equity
-$2.07B
Working capital
-$6.21B
Debt to equity
-3.56
Current ratio
0.9
Quick ratio
0.51
Net debt/EBITDA
0.32
Margins
Efficiency
Dividend
EBITDA margin
1.5%
Gross margin
3.7%
Net margin
0.9%
Operating margin
1.2%
Return on assets
4.5%
Return on equity
N/A
Return on invested capital
62.8%
Return on capital employed
32.8%
Return on sales
1.2%
Dividend yield
0.4%
DPS
$2.84
Payout ratio
11%
MCK stock price
How has the Mckesson stock price performed over time
Intraday
-0.31%
1 week
-1.4%
1 month
-0.23%
1 year
21.04%
YTD
24.48%
QTD
5.41%
Financial performance
How have Mckesson's revenue and profit performed over time
Revenue
$359.05B
Gross profit
$13.32B
Operating income
$4.42B
Net income
$3.3B
Gross margin
3.7%
Net margin
0.9%
MCK's net income is up by 17% QoQ and by 10% YoY
The revenue is up by 16% year-on-year and by 4.2% since the previous quarter
The net margin has grown by 13% since the previous quarter but it has declined by 10% year-on-year
Mckesson's operating income has increased by 13% YoY and by 9% from the previous quarter
Price vs fundamentals
How does MCK's price correlate with its fundamentals
Growth
What is Mckesson's growth rate over time
Valuation
What is Mckesson stock price valuation
P/E
27.43
P/B
N/A
P/S
0.25
EV/EBIT
20.38
EV/EBITDA
17.01
EV/Sales
0.25
The company's EPS rose by 18% QoQ and by 15% YoY
The price to earnings (P/E) is 16% more than the 5-year quarterly average of 23.8 and 6% more than the last 4 quarters average of 25.9
MCK's equity is up by 33% since the previous quarter but it is down by 5% year-on-year
MCK's P/S is 25% above its 5-year quarterly average of 0.2 and 25% above its last 4 quarters average of 0.2
The revenue is up by 16% year-on-year and by 4.2% since the previous quarter
Efficiency
How efficient is Mckesson business performance
The return on invested capital rose by 21% year-on-year and by 15% since the previous quarter
The return on assets has grown by 13% since the previous quarter
The company's return on sales fell by 8% YoY
Dividends
What is MCK's dividend history
DPS
$2.84
Dividend yield
0.4%
Payout ratio
11%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Mckesson financials performed over time
The total assets is 2.2% smaller than the total liabilities
The total assets has grown by 11% year-on-year and by 6% since the previous quarter
Mckesson's quick ratio has increased by 11% from the previous quarter and by 2% YoY
MCK's equity is up by 33% since the previous quarter but it is down by 5% year-on-year
The debt has declined by 24% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.